Nuacht

Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer
Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...
Battle for 23andMe (and its data) grows
The fate of 23andMe (MEHCQ) and the treasure trove of data it has on its users is set to be fought over in court. Yahoo ...
BioPharma Dive14 uair an chloig
FDA clears CSL’s swelling disease drug; Regeneron loses 23andMe auction
The agency cleared CSL’s hereditary angioedema drug days after “resource constraints” delayed a rival medicine. Elsewhere, ...
Regeneron declines to make higher bid for 23andMe after Wojcickis $305 million offer
June 16 - Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on ...
The Independent on MSN6 uair an chloig
23andMe fined millions by watchdog after ‘profoundly damaging’ cyber attack exposing genetic data
Genetic testing firm 23andMe has been fined £2.31 million by the UK's data protection watchdog for "serious security failings ...
River Journal Online10 uair an chloig
Regeneron Outbid in Effort to Acquire 23andMe
Regeneron Pharmaceuticals was outbid in its effort to buy 23andMe by a nonprofit led by the bankrupt genetics testing company’s co-founder. California-based TTAM Research Institute, led by Anne ...
DNA testing firm 23andMe fined £2.31m for ‘serious security failings’
DNA testing firm 23andMe fined £2.31m for ‘serious security failings’ - A cyber attack on the genetic testing firm saw ...
MassDevice11 uair an chloig
23andMe co-founder wins bid to take back control of company
Regeneron Pharmaceuticals had previously agreed to acquire the company for $256 million. TTAM’s higher bid and added consumer protections ultimately led the board’s special committee to select it as ...